Canine T-Cell Lymphoma

Canine T-Cell Lymphoma is a common cancer in large-breed dogs. Lymphoma is a cancer of lymphocytes that affects approximately 13 to 24 dogs per 100,000 annually and accounts for up to 24% of all canine cancer cases in the United States.1 It is characterized by an abnormal population of lymphocytes, which are an important part of the immune system. Lymphoma usually arises in lymphoid tissues, such as the lymph nodes, spleen, and bone marrow, but can be found anywhere in the body. Multicentric lymphoma, which involves multiple lymph nodes and may also affect the spleen, liver, and/or bone marrow, accounts for approximately 80% of canine lymphoma cases. The annual market for the treatment of Canine Lymphoma is estimated to be around $180mm.

+972 522 555338

avi@medc.bio

©2020 Vet1Therapeutics. All Rights Reserved. Proudly created by wix_pro

Vet1 Head Office:

2 Oppenheimer Street

Rehovot, Israel 767010